BAKER Bros. Advisors L.P., 10% Owner at Entrada Therapeutics, Inc. (TRDA), bought 105,382 shares at $5.83 ($631K) on 2022-05-16, disclosed to the SEC on 2022-05-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.83 | 2,063 | $12K | 1.9% |
| 2 | $5.83 | 16,937 | $99K | 15.7% |
| 3 | $5.83 | 16,937 | $99K | 15.7% |
| 4 | $6.13 | 2,010 | $12K | 2.0% |
| 5 | $6.13 | 16,501 | $101K | 16.0% |
| 6 | $6.13 | 16,501 |
| $101K |
| 16.0% |
| 7 | $5.92 | 84 | $497 | 0.1% |
| 8 | $5.92 | 692 | $4K | 0.6% |
| 9 | $6.00 | 3,654 | $22K | 3.5% |
| 10 | $6.00 | 30,003 | $180K | 28.5% |
| Total | $5.98 avg | 105,382 | $631K | 100% |
| Filing → |
| IGMS | BUY | 2024-03-28 | $6.8M | — | Filing → |
| MDGL | BUY | 2023-12-14 | $45.0M | — | Filing → |
| TRDA | BUY | 2022-05-24 | $396K | — | Filing → |